Pfizer Canada Inc. is the Canadian operation of Pfizer Inc, the world's leading pharmaceutical company. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals, as well as many of the world's best-known over-the-counter healthcare products. Pfizer Inc invests more than US$7 billion annually in R&D to discover and develop innovative life-saving and life-enhancing medicines in a wide range of therapeutic areas, including arthritis, cardiovascular disease, endocrinology, HIV/AIDS, infectious disease, neurological disease, oncology, ophthalmology and smoking cessation.
Global headquarters are located in New York City, where the company was founded in 1849. During the Second World War, Pfizer became the first company to mass-produce penicillin, launching Pfizer into the modern pharmaceutical era. Pfizer Canada is one of the top investors in Canadian R&D, investing more than $190 million in 2005. Canadian headquarters of Pfizer Global Pharmaceuticals is in Kirkland, Quebec. Pfizer Canada also operates distribution facilities in Ontario and western Canada.
As one of the top corporate charitable donors in Canada, Pfizer Canada is a proud member of Imagine Canada and its Caring Company program. In 2005, Pfizer Canada's Community Investment Program supported more than 1000 non-profit organizations and projects across the country with a total investment exceeding $17 million. For more information, visit www.pfizer.ca.
For information on
previous conference's, visit our ARCHIVES
For all other inquiries,
contact Jennifer Hughey, Assistant Editor Conferences
This page was last updated on January 14, 2008.
|
